Non-parenteral Ketamine for Depression: A Practical Discussion on Addiction Potential and Recommendations for Judicious Prescribing

Intravenous (IV) ketamine is increasingly used off-label at subanesthetic doses for its rapid antidepressant effect, and intranasal (IN) esketamine has been recently approved in several countries for treating depression. The clinical utility of these treatments is limited by a paucity of publicly fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Swainson, Jennifer, Klassen, Larry J., Brennan, Stefan, Chokka, Pratap, Katzman, Martin A., Tanguay, Robert L., Khullar, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Therapy in Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853036/
https://www.ncbi.nlm.nih.gov/pubmed/35165841
http://dx.doi.org/10.1007/s40263-022-00897-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853036/
https://www.ncbi.nlm.nih.gov/pubmed/35165841
http://dx.doi.org/10.1007/s40263-022-00897-2

Ejemplares similares